The global endoscopy devices market size was estimated at USD 61.06 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.79% from 2025 to 2030. This growth trajectory can be attributed to several key factors, most notably the less invasive nature of endoscopy procedures and the relatively affordable costs associated with pre- and post-procedure care. These advantages make endoscopy an attractive option for both patients and healthcare providers, significantly driving market demand.
In recent years, there has been a notable shift towards the use of disposable endoscopic components. This trend aims to not only reduce overall procedure costs but also to minimize the risk of cross-contamination between patients. By utilizing disposable tools, healthcare facilities can enhance patient safety while streamlining the workflow in surgical settings. This shift is anticipated to further accelerate market growth as hospitals and clinics increasingly adopt these safer, cost-effective practices.
The escalating global burden of cancer is another critical factor propelling the adoption of endoscopy devices. Early diagnosis and treatment are paramount in improving patient outcomes, and endoscopy plays a crucial role in these processes. According to the Cancer Progress Report 2023 published by the American Cancer Society, approximately 2.0 million new cancer cases were diagnosed in the U.S. alone in 2023, with 609,820 fatalities attributed to the disease. Projections indicate that by 2040, new cancer cases could escalate to 2.3 million. The increasing reliance on biopsies for cancer diagnosis is likely to spur further adoption of endoscopic devices, enhancing their market presence.
Technological advancements are also expected to drive significant growth in the endoscopy devices market. Leading manufacturers are committed to innovating and improving endoscopic solutions to enhance the treatment and diagnosis of various chronic conditions. For example, in August 2021, Fujifilm Holdings Corporation announced the commercial launch of the ELUXEO 7000X endoscopic Imaging System. This cutting-edge system provides real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissues during laparoscopic and/or endoluminal imaging procedures, marking a significant advancement in the capabilities of endoscopy devices.
The impact of the COVID-19 pandemic on the endoscopy devices market cannot be overlooked. The pandemic led to a reduction and postponement of elective surgeries due to heightened fears of infection, which adversely affected the market’s growth. Additionally, supply chain disruptions and evolving regulations regarding surgical procedures further hampered market expansion in 2020. A study published in the Arab Journal of Gastroenterology highlighted that the volume of endoscopic procedures was reduced by over 50% in 85% of responding countries during the pandemic, illustrating the severe impact of COVID-19 on this sector.
Gather more insights about the market drivers, restrains and growth of the Endoscopy Devices Market
End Use Segmentation Insights
In 2024, the outpatient facilities segment emerged as the dominant player in the endoscopy devices market, accounting for a substantial revenue share of 53.6%. This segment is expected to witness the fastest growth over the forecast period, driven by an increasing preference for minimally invasive procedures. Facilities such as ambulatory surgery centers and diagnostic clinics are likely to benefit from this trend, as they offer procedures that significantly lower overall costs and reduce hospital stay durations. The advantages of faster recovery times and minimal discomfort associated with less invasive keyhole endoscopic techniques further boost the adoption of endoscopy devices within outpatient settings.
The hospital segment is also projected to experience significant growth during the forecast period. Technological advancements—such as improved imaging systems and the introduction of more sophisticated and precise instruments—are enhancing the safety and efficacy of endoscopic procedures. The rising prevalence of chronic diseases, combined with an aging population, is resulting in an increased volume of diagnostic and therapeutic endoscopic procedures, further supporting growth in this segment.
Moreover, the growing adoption of robotic endoscopy procedures within hospitals is a noteworthy trend that is driving market expansion. For example, in January 2024, the Emirates Health Services (EHS) announced the launch of a novel robotic endoscopy technique aimed at treating hiatal hernia in two hospitals. This innovative approach could revolutionize the treatment landscape for patients suffering from Gastroesophageal Reflux Disease (GERD), underscoring the potential of robotics to transform traditional endoscopic practices.
Overall, the endoscopy devices market is on a promising growth path, influenced by a variety of factors ranging from technological advancements to shifting healthcare practices and the rising global burden of diseases.
Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.
